×
ADVERTISEMENT

OCTOBER 19, 2016

Bringing Immunotherapy For Melanoma to the Front Line

Checkpoint inhibitors have increased survival for thousands of patients. Why do some respond while others do not?

image

After working for Chevron Lubricants for 33 years as a laboratory chemist, Tom Bell was happy to retire in early 2015. His plan was to enjoy his home in the San Francisco Bay Area—camping, fishing, relaxing and spending time with his wife, Connie. But his retirement bliss was cut short a few months later, when Tom began to experience some troublesome symptoms.

It began with fatigue, blurry vision and insomnia, and his primary care physician treated him for depression and insomnia. Then